MEDIA RELEASE 14 August 2020 The National Pharmaceutical Services Association (NPSA) is pleased to announce the appointment of API CEO and Managing Director Richard Vincent as Chair of the NPSA Board. Symbion CEO Brett Barons has been appointed Deputy Chair.
In line with the NPSA’s rotation policy, Sigma CEO and Managing Director Mark Hooper will step down from his role as Chair and will continue to serve on the Board.
Mr Vincent said, “The Board extends sincere thanks to Mark Hooper for his excellent leadership of our industry association which most recently has seen the successful completion of the important 7th Community Pharmacy Agreement (7CPA) negotiations with government.”
NPSA is the peak organisation representing the full-line pharmaceutical wholesalers in Australia (Australian Pharmaceutical Industries, Sigma Healthcare, National Pharmacies and Symbion).
Through a critical infrastructure network of 34 national distribution centres, member companies stock and deliver more than 300 million medicines each year to 5700 pharmacies throughout Australia.
Contact: media@npsa.org.au
Richard Vincent
Chair, CEO & Managing Director
Australian Pharmaceutical Industries Ltd
Chair, National Pharmaceutical Services Association (NPSA)
Brett Barons
Deputy Chair, CEO
Symbion
Deputy Chair, National Pharmaceutical Services Association (NPSA)